AxoGen (NASDAQ:AXGN) is set to announce its earnings results after the market closes on Monday, October 29th. Analysts expect the company to announce earnings of ($0.13) per share for the quarter.
AxoGen (NASDAQ:AXGN) last released its quarterly earnings data on Wednesday, August 1st. The medical equipment provider reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.01). The business had revenue of $20.58 million during the quarter, compared to analysts’ expectations of $21.25 million. AxoGen had a negative return on equity of 26.50% and a negative net margin of 24.96%. AxoGen’s quarterly revenue was up 35.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.04) earnings per share. On average, analysts expect AxoGen to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
NASDAQ:AXGN opened at $32.72 on Friday. The stock has a market capitalization of $1.29 billion, a price-to-earnings ratio of -105.55 and a beta of -0.39. AxoGen has a 12-month low of $19.85 and a 12-month high of $56.85.
In other news, Director Amy Mcbride Wendell bought 5,000 shares of AxoGen stock in a transaction on Tuesday, August 14th. The shares were bought at an average cost of $36.89 per share, for a total transaction of $184,450.00. Following the acquisition, the director now owns 18,333 shares in the company, valued at $676,304.37. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 7.86% of the stock is currently owned by corporate insiders.
AxoGen, Inc develops and markets surgical solutions for peripheral nerve injuries. The company's surgical solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments.
Read More: How Do Tariffs Affect Trade Balances?
Receive News & Ratings for AxoGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AxoGen and related companies with MarketBeat.com's FREE daily email newsletter.